Journal profile · HEALTH CARE SCIENCES & SERVICES
ClinicoEconomics and Outcomes Research
ISSN 1178-6981 · Dove Medical Press · United Kingdom
ClinicoEconomics and Outcomes Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5 (journal website); JCR Q2 (journal website); fully open access; APC about USD 3,565; median 111 days to acceptance (101 articles, last 24 months); acceptance rate 46% (journal website); 74 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
ClinicoEconomics and Outcomes Research is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer and Medication Adherence and Compliance, together about 27% of its articles. Its main subfields are Economics and Econometrics. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Giorgio Colombo ClinicoEconomics and Outcomes Research is an international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage. ClinicoEconomics and Outcomes Research will no longer consider meta-analyses for publication. The aim of the journal is to rapidly and concisely publish outcomes studies, methodologies, reviews, and reports across all disease areas. In addition, evaluations investigating prescribing behavior, practice guidelines, cost-of-illness, cost of treatment, and cost-effectiveness will be welcome. The journal will also specifically explore patient reported outcomes, satisfaction, preference and adherence, willingness-to-pay (WTP), cost-utility, cost-benefit, disease management strategies, and drug health & policy. Papers reporting on the effective deployment of diagnostic, screening, clinical and surgical interventions, and the use of medicines and devices to maximize healthcare resources for the benefit of the patient will be given particular priority. Updated 16 July 2025
From the journal's Aims & Scope
Research area (LetPub): HEALTH CARE SCIENCES & SERVICES
Editor-in-chief Colombo ScientificPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 9, Spain 6, United Kingdom 4, India 4, Indonesia 4 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance13.9%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance6.9%
- Medication Adherence and ComplianceMedicine6.2%
- Healthcare Systems and ReformsEconomics, Econometrics and Finance5.5%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance5.2%
- Global Maternal and Child HealthMedicine4.9%
- Rheumatoid Arthritis Research and TherapiesMedicine4.5%
- Diabetes Treatment and ManagementMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- 5-year impact factor (publisher)
- 4.2Publisher website ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore (publisher) 2025
- 1.19Publisher website ·
- SJR 2026-06
- 0.79LetPub ·
- SNIP 2026-06
- 1.19LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 489OpenAlex ·
- 2-year mean citedness
- 2.11OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 99.48%LetPub ·
Volume
- Articles per year
- 73LetPub ·
- Downloads per year (publisher)
- 85,889Publisher website ·
Articles by year OpenAlex count · 1,046 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 60 | 7 |
| 2025 | 74 | 74 | 166 |
| 2024 | 62 | 62 | 241 |
| 2023 | 67 | 67 | 760 |
| 2022 | 61 | 61 | 865 |
| 2021 | 90 | 90 | 1,141 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
111 daysMedian, submission to acceptance · P25–P75 85 days – 138 days
- Acceptance to online
- median 15 days (101 articles)
- Submission to online
- median 131 days
- Sample
- 101 articles with submission and acceptance dates (149 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 46%Publisher website ·
- Desk decision
- 46 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,565 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- editorialEditorialLength not stated
- letterLetterLength not stated
- original researchOriginal ResearchLength not stated
- response to letterResponse to LetterLength not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics, Plagiarism
- Publication ethics
COPE member Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1178-6981
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ClinicoEconomics and Outcomes Research
What CAS zone is ClinicoEconomics and Outcomes Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, ClinicoEconomics and Outcomes Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Health Care Sciences & Services. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ClinicoEconomics and Outcomes Research?
The journal's website gives an impact factor of 2.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.2, h-index 53.
How long does peer review take at ClinicoEconomics and Outcomes Research?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 85–138 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 46%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is ClinicoEconomics and Outcomes Research in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of ClinicoEconomics and Outcomes Research based?
Of the 43 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (9), Spain (6) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index ClinicoEconomics and Outcomes Research?
According to LetPub and DOAJ records, ClinicoEconomics and Outcomes Research is indexed in ESCI, Scopus and DOAJ.
Is ClinicoEconomics and Outcomes Research open access, and what is the APC?
ClinicoEconomics and Outcomes Research is a fully open-access journal. APC about USD 3,565.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .